Results 21 to 30 of about 617,524 (267)
Frontiers in Medicine, 2021 Objective: We aimed to explore the dynamic changes in coagulation function and the effect of age on coagulation function in patients with pneumonia under admission and non-admission treatment.Methods: We included 178 confirmed adult inpatients with COVID-
Jiasheng Xu +17 more
doaj +1 more source
Risk factor targeting for vaccine prioritization during the COVID-19 pandemic
Scientific Reports, 2022 A key public health question during any disease outbreak when limited vaccine is available is who should be prioritized for early vaccination. Most vaccine prioritization analyses only consider variation in risk of infection and death by a single risk ...
Lloyd A. C. Chapman +8 more
doaj +1 more source
New Scientist, 2020 The coronavirus has mutated very little, but as more people are treated or vaccinated it could face pressure to evolve, finds Graham Lawton.
openaire +2 more sources
Frontiers in Cellular and Infection Microbiology, 2022 The COVID-19 disease presents a large range of clinical manifestations and includes asymptomatic, mild, and severe cases. The level of severity is related to parameters associated with immunity, genetics, and biochemistry.
Nadine N’dilimabaka +17 more
doaj +1 more source
Uirusu, 2003 SARS is a new type of infectious pneumonia that emerged in China in November 2002. It spread around the world through an outbreak in Hong Kong in March 2003. Patients were reported in 29 countries, and around 800 people died, although a majority of these cases were in Asian countries.
openaire +4 more sources
The Coronavirus Replicase [PDF]
, 2005 Coronavirus genome replication and transcription take place at cytoplasmic membranes and involve coordinated processes of both continuous and discontinuous RNA synthesis that are mediated by the viral replicase, a huge protein complex encoded by the 20-kb replicase gene. The replicase complex is believed to be comprised of up to 16 viral subunits and a
openaire +2 more sources
Insights into coronavirus immunity taught by the murine coronavirus
European Journal of Immunology, 2021 AbstractCoronaviruses (CoVs) represent enveloped, ss RNA viruses with the ability to infect a range of vertebrates causing mainly lung, CNS, enteric, and hepatic disease. While the infection with human CoV is commonly associated with mild respiratory symptoms, the emergence of SARS‐CoV, MERS‐CoV, and SARS‐CoV‐2 highlights the potential for CoVs to ...
Sarah Grabherr +2 more
openaire +3 more sources
Frontiers in Public Health, 2022 COVID-19, referred to as new coronary pneumonia, is an acute infectious disease caused by a new type of coronavirus SARS-CoV-2. To evaluate the effect of integrated Chinese medicine and Western medicine in patients with COVID-19 from overseas.
Yu-Xuan Huang +15 more
doaj +1 more source
SSRN Electronic Journal, 2020 AbstractThis study examines racial disparities in the impact of the COVID‐19 pandemic in the United States, focusing on factors influencing infection and mortality rates at the county level. We find compelling evidence of disproportionate effects on ethnic minority groups, particularly Blacks, Hispanic Americans, and Native Americans.
Cong S. Pham, Devashish Mitra
openaire +1 more source
Protection from infection and reinfection due to the Omicron BA.1 variant in care homes
Frontiers in Immunology, 2023 IntroductionFollowing the emergence of SARS-CoV-2 in 2020, care homes were disproportionately impacted by high mortality and morbidity of vulnerable elderly residents.
Saher Choudhry +10 more
doaj +1 more source